Skip to main content


Mobile Hospital
JTS Mission

The mission of the Joint Trauma System (JTS) is to improve trauma readiness and outcomes through evidence-driven performance improvement. The JTS vision is that every Soldier, Sailor, Airman and Marine injured on the battlefield or in any theater of operations will be provided with the optimum chance for survival and maximum potential for functional recovery.

Critical Care Air Transport Team Unloading
Performance Improvement

JTS supports US military performance improvement (PI) initiatives and activities by identifying, tracking and making recommendations on efforts to ensure the appropriate evaluation and treatment of injured Service members across the continuum of care, improve medic training and ensure medical readiness.

Naval Weapons Station Trauma
Trauma Registry

The DoDTR is the first and only DoD trauma patient registry to collect combat casualty care epidemiology, treatments and outcomes from point of injury to recovery. The DoDTR contains identified information taken from medical records, expert clinical inference, scoring and coding schematics, probability determination and PI data.

Army Medical Field Training
JTS Operations

As the DoD Center of Excellence for MHS trauma care delivery, JTS provides the overarching organized and coordinated capability for injury prevention, care and rehabilitation in support of DoD trauma initiatives and activities. JTS performs these functions through Trauma Care Operations; the DoDTR; and PI and Education Divisions.

JTS Study Poster Awarded MHSRS 2019 Best of Show
JTS wins MHSRS Best of Show

A JTS study has received global recognition by peers in the military medical community, winning the "Best of Show" poster at this year's Military Health System Research Symposium, Aug 19-22. The poster, which provided an overview of a descriptive study of U.S. Special Operations Command (SOCOM) fatalities, was chosen out of more than 1,500 entries. The JTS retrospective review and descriptive analysis focused on SOCOM fatalities who died while performing duties from 11 Sep 2001 to 10 Sep 2018. Characteristics analyzed included subcommand, military activity, operational posture, and manner of death. Studies of fatalities from injury and disease guide prevention and treatment efforts for populations at risk. In this case, the study confirmed that leaders must continue to optimize prehospital capability and develop strategies that rapidly connect patients to advanced resuscitative and surgical care to improve survival from military activities worldwide.

Vice Admiral Raquel C. Bono, Director, DHA, commended the team in her farewell email. "Congratulations on your great work, highlighting the epidemiology of 614 SOCOM fatalities since 2001, and for your ongoing efforts to study preventability and survivability using operational and medical data," Bono stated. "Your work exemplifies the symposium's focus on translating research into enhanced readiness and care for the warfighter. Excellent work!"

Team: Russ S. Kotwal, MD, MPH, Edward L. Mazuchowski, MD, PhD, Caryn A. Stern, DrPH, MPH, Harold R. Montgomery, BA, JudC. Janak, PhD, Jeffrey T. Howard, PhD, Frank K .Butler, MD, John B. Holcomb, MD, Brian J. Eastridge, MD, Jennifer M. Gurney, MD, and Stacy A. Shackelford, MD.

New Damage Control Resuscitation CPG Now Available

The JTS has published the updated Damage Control Resuscitation (DCR) Clinical Practice Guideline (CPG) filled with life-saving recommendations based on the latest research and best practices built on lessons learned on the frontlines and in medical treatment facilities. Below is a summary of changes found in the DCR CPG.

  • Greater emphasis on the use of Low Titer O Whole Blood
  • Updated risk factors for massive transfusion
  • Earlier use of calcium use recommended for hemorrhagic shock (with transfusion) and for ongoing resuscitation
  • Adjusted blood pressure goals for DCR for traumatic brain injury
  • Resuscitative Endovascular Balloon Occlusion of the Aorta updated as a fielded option for the control of non-compressible torso hemorrhage by resuscitation teams.
  • The discontinued use of hydroxyethyl starch (i.e. Hextend, Hespan) as a resuscitation fluid
  • The discontinued use of recombinant human activated factor VII
The Tactical Combat Casualty Care (TCCC) Guidelines were developed by the Committee on Tactical Combat Casualty Care to providing military personnel with the resources to facilitate implementing best medical practices in battlefield trauma care. Through supporting the training of deploying and deployed U.S. military personnel, the material can be used by individuals to engage in self-directed learning, and by instructors as training aids to supplement formal courseware.
JTS Recognized for Advancing Military Medicine
The Henry M. Jackson Foundation (HJF) for the Advancement of Military Medicine selected the Joint Trauma System (JTS) to receive the 2020 Hero of Military Medicine (HMM) Ambassador Award. The HMM Award recognizes outstanding contributions by senior leaders, medical professionals, and civilians who have distinguished themselves through excellence and dedication to advancing military medicine and enhancing the lives and health of our Nation's wounded, ill and injured Service Members, Veterans and their Families. The JTS mission to improve trauma readiness and outcomes through evidence-driven performance improvement processes aligns perfectly with the HJF mission to advance military medicine. Additionally, the vision of the JTS embodies the true spirit of collaboration, which is a pillar of the Ambassador award.